CClinicalTrials.gg
CompletedNCT04273308Updated Feb 18, 2020

The Effect of Whole-body Vibration Training

An interventional study of whole-body vibration training in Biomarkers, sponsored by National Taipei University of Nursing and Health Sciences. Completed. Open to participants aged 65 Years to 99 Years. Per ClinicalTrials.gov, last updated 2020-02-18.

Sponsored by National Taipei University of Nursing and Health Sciences · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 3 years 7 months after the study started (first participant enrolled Mar 2016, registered Nov 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Not applicable
Ages
65 Years to 99 Years
Sex
All
01

Study summary

The whole-body vibration programme employed in this study partly improved the biomarkers and health beliefs of the prefrail community-dwelling older adults.

Read the detailed description

The experimental group participated in a 12-week whole-body vibration training that conducted 3 times per week, with 5-min continuous vibration at 12-Hz frequency and 3-mm amplitude each time

02

Conditions studied

  • Biomarkers

Keywords

  • older adults
  • community
  • frailty biomarkers
  • health belief
  • prefrailty
  • quasi-experimental design
  • whole-body vibration training
03

In context

Lead sponsor

National Taipei University of Nursing and Health Sciences is the lead sponsor of 119 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age of 65 years or older and living in a community
  • Full consciousness and able to communicate verbally
  • No severe cognitive disorder

Exclusion criteria

Exclusion Criteria:

  • Impaired mobility after recent surgery
  • Major illness such as cancer
  • Severe hearing impairment and inability to fully understand and follow instructions
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
42 participants (actual)

Study arms

  • Experimental
    whole-body vibration training

    a 12-week whole-body vibration training that conducted 3 times per week, with 5-min continuous vibration at 12-Hz frequency and 3-mm amplitude each time.

    Device: whole-body vibration training

Interventions

  • Devicewhole-body vibration training

    The experimental group participated in a 12-week whole-body vibration training that was conducted 3 times per week, with 5-min continuous vibration at 12-Hz frequency and 3-mm amplitude each time. The control group were provided home DVDs on resistance exercise and manuals for preventing frailty

06

What researchers measure

Primary outcomes

  1. Pretest and posttest results of the experimental and control groups for Grip strength

    Comparison of grip strength before and after 12 weeks of training

    Time frame: Change from baseline at 12 weeks (The experimental group participated training that was conducted 3 times per week, with 5-min continuous vibration)

  2. Pretest and posttest results of the experimental and control groups for 15-foot walk test speed

    Comparison of 15-foot walk test speed before and after 12 weeks of training

    Time frame: Change from baseline at 12 weeks (The experimental group participated training that was conducted 3 times per week, with 5-min continuous vibration)

  3. Pretest and posttest results of the experimental and control groups for One-leg standing test using the dominant leg with the eyes open

    Comparison of One-leg standing test with the eyes open before and after 12 weeks of training

    Time frame: Change from baseline at 12 weeks (The experimental group participated training that was conducted 3 times per week, with 5-min continuous vibration)

  4. Pretest and posttest results of the experimental and control groups for Thirty-second chair stand test

    Comparison of Thirty-second chair stand test before and after 12 weeks of training

    Time frame: Change from baseline at 12 weeks (The experimental group participated training that was conducted 3 times per week, with 5-min continuous vibration)

  5. Pretest and posttest results of the experimental and control groups for Two-minute step test

    Comparison of Two-minute step test before and after 12 weeks of training

    Time frame: Change from baseline at 12 weeks (The experimental group participated training that was conducted 3 times per week, with 5-min continuous vibration)

  6. Pretest and posttest results of the experimental and control groups for Health beliefs

    Comparison of health beliefs before and after 12 weeks

    Time frame: The twelfth week

Secondary outcomes

  1. Summary of posttest ANCOVA of the experimental and control groups for biomarkers

    One-way ANCOVA was conducted using the groups as the independent variable and the pretest results and sex as covariate variables to assess the intervention effectiveness

    Time frame: The twelfth week

  2. Summary of posttest ANCOVA of the experimental and control groups for health beliefs

    One-way ANCOVA was conducted using the groups as the independent variable and the pretest results and sex as covariate variables to assess the intervention effectiveness

    Time frame: The twelfth week

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 18, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04273308
Lead sponsor
National Taipei University of Nursing and Health Sciences
Responsible party
HUI CHUN YANG (Principal Investigator, National Taipei University of Nursing and Health Sciences) — Principal investigator
First posted
Feb 18, 2020
Start date
Mar 18, 2016
Primary completion
Jun 25, 2016
Completion
Jun 25, 2016
Last update
Feb 18, 2020

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion